Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023 Aug 4, 2023
Iterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trials Apr 20, 2023
Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 Mar 9, 2023
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem Dec 15, 2022
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022 Nov 3, 2022
